It is clear that the regulation of PTX3 in pregnancy is complex, and the different profiles observed in GDM and preeclampsia patients may reflect contributions from different sources depending on the presence and extent of acute or chronic inflammatory conditions. This evidence concerns the gene PTX3 and gestational diabetes.